Our results suggested that both gene and protein expression levels of ENTPD5 showed an effect on COVID-19 severity, which provides evidence to support the examination of the direct role of ENTPD5 inhibition on SARS-CoV-2 viral entry and, subsequently, in the prevention of severe COVID-19 in future studies. The gene discussed is ENTPD5; the disease is COVID-19.